Mutant Lipooligosaccharide-Based Conjugate Vaccine Demonstrates a Broad-Spectrum Effectiveness against Moraxella catarrhalis

There is no licensed vaccine available against Moraxella catarrhalis, an exclusive human pathogen responsible for otitis media in children and respiratory infections in adults. We previously developed conjugate vaccine candidates based on lipooligosaccharides (LOSs) of M. catarrhalis serotypes A, B,...

詳細記述

保存先:
書誌詳細
主要な著者: Ren, Dabin, Yu, Shengqing, Gao, Song, Peng, Daxin, Petralia, Ronald S., Muszynski, Artur, Carlson, Russell W., Robbins, John B., Tsai, Chao-Ming, Lim, David J., Gu, Xin-Xing
フォーマット: Artigo
言語:Inglês
出版事項: 2011
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3109615/
https://ncbi.nlm.nih.gov/pubmed/21501641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2011.03.102
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料